COMPARISON OF PREDICT AND ADJUVANT! PROGNOSTICATION MODELS FOR EARLY BREAST CANCER IN A UK DATASET

被引:0
|
作者
Wishart, G. C. [1 ]
Campbell, Helen [1 ]
Azzato, E. M. [1 ]
Greenberg, D. C. [1 ]
Rashbass, J. [1 ]
Caldas, C. [1 ]
Pharoah, P. D. P. [1 ]
机构
[1] Cambridge Breast Unit, Cambridge, England
来源
EJC SUPPLEMENTS | 2010年 / 8卷 / 06期
关键词
D O I
10.1016/j.ejcsup.2010.06.071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O70
引用
收藏
页码:26 / 26
页数:1
相关论文
共 50 条
  • [1] Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years
    Engelhardt, Ellen G.
    van den Broek, Alexandra J.
    Linn, Sabine C.
    Wishart, Gordon C.
    Rutgers, Emiel J. Th.
    van de Velde, Anthonie O.
    Smit, Vincent T. H. B. M.
    Voogd, Adri C.
    Siesling, Sabine
    Brinkhuis, Mariel
    Seynaeve, Caroline
    Westenend, Pieter J.
    Stiggelbout, Anne M.
    Tollenaar, Rob A. E. M.
    van Leeuwen, Flora E.
    van 't Veer, Laura J.
    Ravdin, Peter M.
    Pharaoh, Paul D. P.
    Schmidt, Marjanka K.
    EUROPEAN JOURNAL OF CANCER, 2017, 78 : 37 - 44
  • [2] Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
    Earl, H. M.
    Hiller, L.
    Dunn, J.
    Macpherson, I.
    Rea, D.
    Hughes-Davies, L.
    McAdam, K.
    Hall, P.
    Mansi, J.
    Wheatley, D.
    Abraham, J. E.
    Caldas, C.
    Gasson, S.
    O'Riordan, E.
    Wilcox, M.
    Miles, D.
    Cameron, D. A.
    Wardley, A.
    CLINICAL ONCOLOGY, 2021, 33 (01) : 15 - 19
  • [3] Adjuvant UK: A UK Prognostic Model for Early Breast Cancer That Includes Mode of Detection
    Wishart, G. C.
    Azzato, E.
    Pharoah, P.
    Greenberg, D.
    Rashbass, J.
    Kearins, O.
    Lawrence, G.
    Caldas, C.
    Ravdin, P.
    CANCER RESEARCH, 2009, 69 (24) : 717S - 717S
  • [4] A comparison of oncotype DX and NHS predict to assess the benefit of adjuvant chemotherapy in patients with early breast cancer
    Deshmane, Vinay
    Raniwala, Anuja
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Development of breast cancer risk prediction models using the UK Biobank dataset
    Alajmi, K.
    Lophatananon, A.
    Muir, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S184 - S185
  • [6] Variation in early breast cancer adjuvant therapy practice among UK oncologists
    Moe, M. M.
    BREAST, 2009, 18 : S78 - S78
  • [7] Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer
    Stabellini, Nickolas
    Cao, Lifen
    Towe, Christopher W.
    Miller, Megan E.
    Sousa-Santos, Artur H.
    Amin, Amanda L.
    Montero, Alberto J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (10): : 1011 - +
  • [8] Discussing Validation of the PREDICT Prognostication Tool in Patients With Breast Cancer
    Pharoah, Paul D. P.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (10): : 1107 - 1108
  • [9] Budget impact analysis of anastrozole as adjuvant therapy in the treatment of early breast cancer in the UK
    Benedict, A
    Christie, A
    VALUE IN HEALTH, 2003, 6 (06) : 735 - 735
  • [10] A comparison of chemotherapy recommendations by NPI, Predict, and Oncotype DX testing in UK women with early node positive breast cancer
    Holt, Simon
    Innis, Paige
    Sai-Giridhar, Priyadharshini
    Seerapu, Satish
    CANCER RESEARCH, 2024, 84 (09)